PPARgamma agonists follow an unknown TRAIL in lung cancer.
Lipkowitz
Stanley
S
Laboratory of Cellular, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland USA.
Dennis
Phillip A
PA
D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D006801:Humans; D008024:Ligands; D008175:Lung Neoplasms / Q000378:metabolism*; D047495:PPAR gamma / Q000819:agonists*; D053221:TNF-Related Apoptosis-Inducing Ligand / Q000378:metabolism*
D000970:Antineoplastic Agents; D008024:Ligands; D047495:PPAR gamma; D053221:TNF-Related Apoptosis-Inducing Ligand